Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 103120, 8 pages
http://dx.doi.org/10.1155/2012/103120
Review Article

Pathogenesis of Abdominal Aortic Aneurysms: Role of Nicotine and Nicotinic Acetylcholine Receptors

Department of Cardiovascular Medicine, First People’s Hospital, Shanghai Jiao-Tong University School of Medicine (SJTUSM), Shanghai 200080, China

Received 30 November 2011; Revised 11 January 2012; Accepted 11 January 2012

Academic Editor: François Mach

Copyright © 2012 Zong-Zhuang Li and Qiu-Yan Dai. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. P. Scott, S. G. Bridgewater, and H. A. Ashton, “Randomized clinical trial of screening for abdominal aortic aneurysm in women,” British Journal of Surgery, vol. 89, no. 3, pp. 283–285, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. I. M. Nordon, R. J. Hinchliffe, I. M. Loftus, and M. M. Thompson, “Pathophysiology and epidemiology of abdominal aortic aneurysms,” Nature Reviews Cardiology, vol. 8, no. 2, pp. 92–102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. K. W. Johnston, R. B. Rutherford, M. D. Tilson, D. M. Shah, L. Hollier, and J. C. Stanley, “Suggested standards for reporting on arterial aneurysms,” Journal of Vascular Surgery, vol. 13, no. 3, pp. 452–458, 1991. View at Publisher · View at Google Scholar
  4. J. Golledge, J. Muller, A. Daugherty, and P. Norman, “Abdominal aortic aneurysm: pathogenesis and implications for management,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 12, pp. 2605–2613, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. H. Forsdahl, K. Singh, S. Solberg, and B. K. Jacobsen, “Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the tromsø study, 1994 2001,” Circulation, vol. 119, no. 16, pp. 2202–2208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Shantikumar, R. Ajjan, K. E. Porter, and D. J. A. Scott, “Diabetes and the abdominal aortic aneurysm,” European Journal of Vascular and Endovascular Surgery, vol. 39, no. 2, pp. 200–207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Golledge, M. Karan, C. S. Moran et al., “Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions,” European Heart Journal, vol. 29, no. 5, pp. 665–672, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Miyama, M. M. Dua, J. J. Yeung et al., “Hyperglycemia limits experimental aortic aneurysm progression,” Journal of Vascular Surgery, vol. 52, no. 4, pp. 975–983, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. I. Patel, D. T. A. Hardman, C. M. Fisher, and M. Appleberg, “Current views on the pathogenesis of abdominal aortic aneurysms,” Journal of the American College of Surgeons, vol. 181, no. 4, pp. 371–382, 1995. View at Google Scholar · View at Scopus
  10. I. Nordon, R. Brar, J. Taylor, R. Hinchliffe, I. M. Loftus, and M. M. Thompson, “Evidence from cross-sectional imaging indicates abdominal but not thoracic aortic aneurysms are local manifestations of a systemic dilating diathesis,” Journal of Vascular Surgery, vol. 50, no. 1, pp. 171–176.e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Rudijanto, “The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis,” Acta medica Indonesiana, vol. 39, no. 2, pp. 86–93, 2007. View at Google Scholar · View at Scopus
  12. T. Miyake, M. Aoki, H. Nakashima et al., “Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFκB and ets using chimeric decoy oligonucleotides in a rabbit model,” Gene Therapy, vol. 13, no. 8, pp. 695–704, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Tsuruda, J. Kato, K. Hatakeyama et al., “Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm,” Circulation Research, vol. 102, no. 11, pp. 1368–1377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. K. M. Mata, P. S. Prudente, F. S. Rocha et al., “Combining two potential causes of metalloproteinase secretion causes abdominal aortic aneurysms in rats: a new experimental model,” International Journal of Experimental Pathology, vol. 92, no. 1, pp. 26–39, 2011. View at Publisher · View at Google Scholar
  15. E. L. Henderson, Y. J. Geng, G. K. Sukhova, A. D. Whittemore, J. Knox, and P. Libby, “Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms,” Circulation, vol. 99, no. 1, pp. 96–104, 1999. View at Google Scholar · View at Scopus
  16. A. López-Candales, D. R. Holmes, S. Liao, M. J. Scott, S. A. Wickline, and R. W. Thompson, “Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms,” American Journal of Pathology, vol. 150, no. 3, pp. 993–1007, 1997. View at Google Scholar · View at Scopus
  17. L. J. Walton, I. J. Franklin, T. Bayston et al., “Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms,” Circulation, vol. 100, no. 1, pp. 48–54, 1999. View at Google Scholar · View at Scopus
  18. J. Zhang, J. Schmidt, E. Ryschich, H. Schumacher, and J. R. Allenberg, “Increased apoptosis and decreased density of medial smooth muscle cells in human abdominal aortic aneurysms,” Chinese Medical Journal, vol. 116, no. 10, pp. 1549–1552, 2003. View at Google Scholar · View at Scopus
  19. V. L. Rowe, S. L. Stevens, T. T. Reddick et al., “Vascular smooth muscle cell apoptosis in aneurysmal, occlusive, and normal human aortas,” Journal of Vascular Surgery, vol. 31, no. 3, pp. 567–576, 2000. View at Google Scholar · View at Scopus
  20. R. W. Thompson, S. Liao, and J. A. Curci, “Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms,” Coronary Artery Disease, vol. 8, no. 10, pp. 623–631, 1997. View at Google Scholar · View at Scopus
  21. I. Sinha, A. P. Sinha-Hikim, K. K. Hannawa et al., “Mitochondrial-dependent apoptosis in experimental rodent abdominal aortic aneurysms,” Surgery, vol. 138, no. 4, pp. 806–811, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Satta, Y. Soini, M. Mosorin, and T. Juvonen, “Angiogenesis is associated with mononuclear inflammatory cells in abdominal aortic aneurysms,” Annales Chirurgiae et Gynaecologiae, vol. 87, no. 1, pp. 40–42, 1998. View at Google Scholar · View at Scopus
  23. M. M. Thompson, L. Jones, A. Nasim, R. D. Sayers, and P. R. F. Bell, “Angiogenesis in abdominal aortic aneurysms,” European Journal of Vascular and Endovascular Surgery, vol. 11, no. 4, pp. 464–469, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Diehm, S. Di Santo, T. Schaffner et al., “Severe structural damage of the seemingly non-diseased infrarenal aortic aneurysm neck,” Journal of Vascular Surgery, vol. 48, no. 2, pp. 425–434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Choke, G. W. Cockerill, J. Dawson et al., “Increased angiogenesis at the site of abdominal aortic aneurysm rupture,” Annals of the New York Academy of Sciences, vol. 1085, pp. 315–319, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Stolle, A. Berges, M. Lietz, S. Lebrun, and T. Wallerath, “Cigarette smoke enhances abdominal aortic aneurysm formation in angiotensin II-treated apolipoprotein E-deficient mice,” Toxicology Letters, vol. 199, no. 3, pp. 403–409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Hukkanen, P. Jacob, and N. L. Benowitz, “Metabolism and disposition kinetics of nicotine,” Pharmacological Reviews, vol. 57, no. 1, pp. 79–115, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Razani-Boroujerdi, R. T. Boyd, M. I. Dávila-García et al., “T cells express α7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca2+ response,” Journal of Immunology, vol. 179, no. 5, pp. 2889–2898, 2007. View at Google Scholar · View at Scopus
  29. J. C. F. Wu, A. Chruscinski, V. A. De Jesus Perez et al., “Cholinergic modulation of angiogenesis: role of the 7 nicotinic acetylcholine receptor,” Journal of Cellular Biochemistry, vol. 108, no. 2, pp. 433–446, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Zhang, A. L. Marshall, A. L. Thomas et al., “In vivo knockdown of nicotinic acetylcholine receptor α1 diminishes aortic atherosclerosis,” Atherosclerosis, vol. 215, no. 1, pp. 34–42, 2011. View at Publisher · View at Google Scholar
  31. G. Zhang, K. A. Kernan, A. Thomas et al., “A novel signaling pathway: fibroblast nicotinic receptor α1 binds urokinase and promotes renal fibrosis,” Journal of Biological Chemistry, vol. 284, no. 42, pp. 29050–29064, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. J. P. Cooke and Y. T. Ghebremariam, “Endothelial nicotinic acetylcholine receptors and angiogenesis,” Trends in Cardiovascular Medicine, vol. 18, no. 7, pp. 247–253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Lee and J. P. Cooke, “The role of nicotine in the pathogenesis of atherosclerosis,” Atherosclerosis, vol. 215, no. 2, pp. 281–283, 2011. View at Publisher · View at Google Scholar
  34. V. Treska, J. Kocova, L. Boudova et al., “Inflammation in the wall of abdominal aortic aneurysm and its role in the symptomatology of aneurysm,” Cytokines, Cellular and Molecular Therapy, vol. 7, no. 3, pp. 91–97, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. D. J. Parry, H. S. Al-Barjas, L. Chappell, S. T. Rashid, R. A. S. Ariëns, and D. J. A. Scott, “Markers of inflammation in men with small abdominal aortic aneurysm,” Journal of Vascular Surgery, vol. 52, no. 1, pp. 145–151, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Swedenborg, M. I. Mäyränpää, and P. T. Kovanen, “Mast cells: Important players in the orchestrated pathogenesis of abdominal aortic aneurysms,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 4, pp. 734–740, 2011. View at Publisher · View at Google Scholar
  37. W. L. Chan, N. Pejnovic, T. V. Liew, and H. Hamilton, “Predominance of Th2 response in human abdominal aortic aneurysm: mistaken identity for IL-4-producing NK and NKT cells?” Cellular Immunology, vol. 233, no. 2, pp. 109–114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. S. B. Police, S. E. Thatcher, R. Charnigo, A. Daugherty, and L. A. Cassis, “Obesity promotes inflammation in periaortic adipose tissue and angiotensin ii-induced abdominal aortic aneurysm formation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 10, pp. 1458–1464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. H. A. Uchida, F. Kristo, D. L. Rateri et al., “Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice,” Atherosclerosis, vol. 211, no. 2, pp. 399–403, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Wang, H. Ait-Oufella, O. Herbin et al., “TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice,” Journal of Clinical Investigation, vol. 120, no. 2, pp. 422–432, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Takai, D. Jin, and M. Miyazaki, “New approaches to blockade of the renin-angiotensin-aldosterone system: chymase as an important target to prevent organ damage,” Journal of Pharmacological Sciences, vol. 113, no. 4, pp. 301–309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Cirillo, M. Pacileo, S. De Rosa et al., “HMG-CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells,” Journal of Vascular Research, vol. 44, no. 6, pp. 460–470, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Albaugh, E. Bellavance, L. Strande, S. Heinburger, C. W. Hewitt, and J. B. Alexander, “Nicotine induces mononuclear leukocyte adhesion and expression of adhesion molecules, VCAM and ICAM, in endothelial cells in vitro,” Annals of Vascular Surgery, vol. 18, no. 3, pp. 302–307, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. P. P. Lau, L. Li, A. J. Merched, A. L. Zhang, K. W. S. Ko, and L. Chan, “Nicotine induces proinflammatory responses in macrophages and the aorta leading to acceleration of atherosclerosis in low-density lipoprotein receptor-/- mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 1, pp. 143–149, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Haverslag, G. Pasterkamp, and I. E. Hoefer, “Targeting adhesion molecules in cardiovascular disorders,” Cardiovascular and Hematological Disorders—Drug Targets, vol. 8, no. 4, pp. 252–260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Yoshikawa, M. Kurokawa, N. Ozaki et al., “Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-κB phosphorylation and nuclear factor-κB transcriptional activity through nicotinic acetylcholine receptor α7,” Clinical and Experimental Immunology, vol. 146, no. 1, pp. 116–123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. X. Wang, Z. Yang, B. Xue, and H. Shi, “Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance,” Endocrinology, vol. 152, no. 3, pp. 836–846, 2011. View at Publisher · View at Google Scholar
  48. N. Sharentuya, T. Tomimatsu, K. Mimura et al., “Nicotine suppresses interleukin-6 production from vascular endothelial cells: a possible therapeutic role of nicotine for preeclampsia,” Reproductive Sciences, vol. 17, no. 6, pp. 556–563, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Balakumar and J. Kaur, “Is nicotine a key player or spectator in the induction and progression of cardiovascular disorders?” Pharmacological Research, vol. 60, no. 5, pp. 361–368, 2009. View at Publisher · View at Google Scholar
  50. C. L. Gentry and R. J. Lukas, “Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure,” Current Drug Targets. CNS and Neurological Disorders, vol. 1, no. 4, pp. 359–385, 2002. View at Google Scholar · View at Scopus
  51. K. S. Chapple, D. J. Parry, S. McKenzie, K. A. MacLennan, P. Jones, and D. J. A. Scott, “Cyclooxygenase-2 expression and its association with increased angiogenesis in human abdominal aortic aneurysms,” Annals of Vascular Surgery, vol. 21, no. 1, pp. 61–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. V. L. King, D. B. Trivedi, J. M. Gitlin, and C. D. Loftin, “Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 5, pp. 1137–1143, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Zhou, Z. X. Wang, M. P. Tang et al., “Nicotine induces cyclooxygenase-2 and prostaglandin E2 expression in human umbilical vein endothelial cells,” International Immunopharmacology, vol. 10, no. 4, pp. 461–466, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. V. Y. Shin, W. K. K. Wu, K. M. Chu et al., “Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer,” Molecular Cancer Research, vol. 3, no. 11, pp. 607–615, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. C. D. Funk, R. Y. Cao, L. Zhao, and A. J. R. Habenicht, “Is there a role for the macrophage 5-lipoxygenase pathway in aortic aneurysm development in apolipoprotein E-deficient mice?” Annals of the New York Academy of Sciences, vol. 1085, pp. 151–160, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Zhao, M. P. W. Moos, R. Gräbner et al., “The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm,” Nature Medicine, vol. 10, no. 9, pp. 966–973, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Di Gennaro, D. Wagsáter, M. I. Máyránpáá et al., “Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 49, pp. 21093–21097, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. X. Houard, V. Ollivier, L. Louedec, J. B. Michel, and M. Bäck, “Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus,” FASEB Journal, vol. 23, no. 5, pp. 1376–1383, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. N. Ye, E. S. L. Liu, V. Y. Shin, W. K. K. Wu, J. C. Luo, and C. H. Cho, “Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway,” Journal of Pharmacology and Experimental Therapeutics, vol. 308, no. 1, pp. 66–72, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Takagi and T. Umemoto, “Smoking promotes pathogenesis of aortic aneurysm through the 5-lipoxygenase pathway,” Medical Hypotheses, vol. 64, no. 6, pp. 1117–1119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Shimizu, R. N. Mitchell, and P. Libby, “Inflammation and cellular immune responses in abdominal aortic aneurysms,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 5, pp. 987–994, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. K. M. Newman, Y. Ogata, A. M. Malon et al., “Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm,” Arteriosclerosis and Thrombosis, vol. 14, no. 8, pp. 1315–1320, 1994. View at Google Scholar · View at Scopus
  63. K. M. Newman, A. M. Malon, R. D. Shin, J. V. Scholes, W. G. Ramey, and M. D. Tilson, “Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources,” Connective Tissue Research, vol. 30, no. 4, pp. 265–276, 1994. View at Google Scholar · View at Scopus
  64. E. Irizarry, K. M. Newman, R. H. Gandhi et al., “Demonstration of interstitial collagenase in abdominal aortic aneurysm disease,” Journal of Surgical Research, vol. 54, no. 6, pp. 571–574, 1993. View at Publisher · View at Google Scholar · View at Scopus
  65. J. M. Reilly, C. M. Brophy, and M. D. Tilson, “Characterization of an elastase from aneurysmal aorta which degrades intact aortic elastin,” Annals of Vascular Surgery, vol. 6, no. 6, pp. 499–502, 1992. View at Publisher · View at Google Scholar · View at Scopus
  66. R. W. Thompson, D. R. Holmes, R. A. Mertens et al., “Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm- infiltrating macrophages,” Journal of Clinical Investigation, vol. 96, no. 1, pp. 318–326, 1995. View at Google Scholar · View at Scopus
  67. W. D. McMillan, B. K. Patterson, R. R. Keen, V. P. Shively, M. Cipollone, and W. H. Pearce, “In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 8, pp. 1139–1144, 1995. View at Google Scholar · View at Scopus
  68. T. Freestone, R. J. Turner, A. Coady, D. J. Higman, R. M. Greenhalgh, and J. T. Powell, “Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 8, pp. 1145–1151, 1995. View at Google Scholar · View at Scopus
  69. W. D. McMillan, B. K. Patterson, R. R. Keen, and W. H. Pearce, “In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta,” Journal of Vascular Surgery, vol. 22, no. 3, pp. 295–305, 1995. View at Publisher · View at Google Scholar · View at Scopus
  70. V. Davis, R. Persidskaia, L. Baca-Regen et al., “Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 10, pp. 1625–1633, 1998. View at Google Scholar · View at Scopus
  71. W. B. Keeling, P. A. Armstrong, P. A. Stone, D. F. Bandyk, and M. L. Shames, “An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms,” Vascular and Endovascular Surgery, vol. 39, no. 6, pp. 457–464, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. J. D. Raffetto and R. A. Khalil, “Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease,” Biochemical Pharmacology, vol. 75, no. 2, pp. 346–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. R. B. Rucker and D. Tinker, “Structure and metabolism of arterial elastin,” International Review of Experimental Pathology, vol. 17, pp. 1–47, 1977. View at Google Scholar · View at Scopus
  74. V. Lemaître, A. J. Dabo, and J. D'Armiento, “Cigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signaling,” Toxicological Sciences, vol. 123, no. 2, pp. 542–549, 2011. View at Publisher · View at Google Scholar
  75. A. L. B. Jacob-Ferreira, A. C. T. Palei, S. B. Cau et al., “Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine,” European Journal of Pharmacology, vol. 627, no. 1–3, pp. 216–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. B. K. Nordskog, A. D. Blixt, W. T. Morgan, W. R. Fields, and G. M. Hellmann, “Matrix-degrading and pro-inflammatory changes in human vascular endothelial cells exposed to cigarette smoke condensate,” Cardiovascular Toxicology, vol. 3, no. 2, pp. 101–117, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. C. Reeps, J. Pelisek, S. Seidl et al., “Inflammatory infiltrates and neovessels are relevant sources of MMPs in abdominal aortic aneurysm wall,” Pathobiology, vol. 76, no. 5, pp. 243–252, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. E. A. Murphy, D. Danna-Lopes, I. Sarfati, S. K. Rao, and J. R. Cohen, “Nicotine-stimulated elastase activity release by neutrophils in patients with abdominal aortic aneurysms,” Annals of Vascular Surgery, vol. 12, no. 1, pp. 41–45, 1998. View at Publisher · View at Google Scholar · View at Scopus
  79. C. S. Carty, P. D. Soloway, S. Kayastha et al., “Nicotine and cotinine stimulate secretion of basic fibroblast growth factor and affect expression of matrix metalloproteinases in cultured human smooth muscle cells,” Journal of Vascular Surgery, vol. 24, no. 6, pp. 927–935, 1996. View at Publisher · View at Google Scholar · View at Scopus
  80. A. M. Dom, A. W. Buckley, K. C. Brown et al., “The α7-nicotinic acetylcholine receptor and MMP-2/-9 pathway mediate the proangiogenic effect of nicotine in human retinal endothelial cells,” Investigative Ophthalmology & Visual Science, vol. 52, no. 7, pp. 4428–4438, 2011. View at Google Scholar
  81. T. Katono, T. Kawato, N. Tanabe et al., “Effects of nicotine and lipopolysaccharide on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in human osteoblasts,” Archives of Oral Biology, vol. 54, no. 2, pp. 146–155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. D. Yamanouchi, S. Morgan, K. Kato, J. Lengfeld, F. Zhang, and B. Liu, “Effects of caspase inhibitor on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 4, pp. 702–707, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Raveendran, J. Wang, D. Senthil et al., “Endogenous nitric oxide activation protects against cigarette smoking induced apoptosis in endothelial cells,” FEBS Letters, vol. 579, no. 3, pp. 733–740, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. R. Aldonyte, E. T. Hutchinson, B. Jin et al., “Endothelial alpha-1-antitrypsin attenuates cigarette smoke induced apoptosis in vitro,” COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 5, no. 3, pp. 153–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Wang, D. E. L. Wilcken, and X. L. Wang, “Cigarette smoke activates caspase-3 to induce apoptosis of human umbilical venous endothelial cells,” Molecular Genetics and Metabolism, vol. 72, no. 1, pp. 82–88, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. C. L. Hsu, Y. L. Wu, G. J. Tang, T. S. Lee, and Y. R. Kou, “Ginkgo biloba extract confers protection from cigarette smoke extract-induced apoptosis in human lung endothelial cells: role of heme oxygenase-1,” Pulmonary Pharmacology and Therapeutics, vol. 22, no. 4, pp. 286–296, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Cucina, A. Fuso, P. Coluccia, and A. Cavallaro, “Nicotine inhibits apoptosis and stimulates proliferation in aortic smooth muscle cells through a functional nicotinic acetylcholine receptor,” Journal of Surgical Research, vol. 150, no. 2, pp. 227–235, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Hakki, H. Friedman, and S. Pross, “Nicotine modulation of apoptosis in human coronary artery endothelial cells,” International Immunopharmacology, vol. 2, no. 10, pp. 1403–1409, 2002. View at Publisher · View at Google Scholar · View at Scopus
  89. R. L. Silverstein and R. L. Nachman, “Angiogenesis and atherosclerosis: the mandate broadens,” Circulation, vol. 100, no. 8, pp. 783–785, 1999. View at Google Scholar · View at Scopus
  90. P. Carmeliet and R. K. Jain, “Angiogenesis in cancer and other diseases,” Nature, vol. 407, no. 6801, pp. 249–257, 2000. View at Publisher · View at Google Scholar · View at Scopus
  91. T. Pralhad, S. Madhusudan, and K. Rajendrakumar, “Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases,” Journal of Pharmacy and Pharmacology, vol. 55, no. 8, pp. 1045–1053, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Wang, E. F. R. Pereira, A. D. J. Maus et al., “Human bronchial epithelial and endothelial cells express α7 nicotinic acetylcholine receptors,” Molecular Pharmacology, vol. 60, no. 6, pp. 1201–1209, 2001. View at Google Scholar · View at Scopus
  93. A. C. Villablanca, “Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro,” Journal of Applied Physiology, vol. 84, no. 6, pp. 2089–2098, 1998. View at Google Scholar · View at Scopus
  94. Y. Zhen, Y. Ruixing, B. Qi, and W. Jinzhen, “Nicotine potentiates vascular endothelial growth factor expression in balloon-injured rabbit aortas,” Growth Factors, vol. 26, no. 5, pp. 284–292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. Y. Kanda and Y. Watanabe, “Nicotine-induced vascular endothelial growth factor release via the EGFR-ERK pathway in rat vascular smooth muscle cells,” Life Sciences, vol. 80, no. 15, pp. 1409–1414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  96. H. R. Arias, V. E. Richards, D. Ng, M. E. Ghafoori, V. Le, and S. A. Mousa, “Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 7, pp. 1441–1451, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. C. Heeschen, M. Weis, A. Aicher, S. Dimmeler, and J. P. Cooke, “A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors,” Journal of Clinical Investigation, vol. 110, no. 4, pp. 527–536, 2002. View at Publisher · View at Google Scholar · View at Scopus
  98. H. Konishi, J. Wu, and J. P. Cooke, “Chronic exposure to nicotine impairs cholinergic angiogenesis,” Vascular Medicine, vol. 15, no. 1, pp. 47–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. C. Heeschen, J. J. Jang, M. Weis et al., “Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis,” Nature Medicine, vol. 7, no. 7, pp. 833–839, 2001. View at Publisher · View at Google Scholar · View at Scopus